“This artificial pancreas could one day greatly improve the current methods of self treatment for Type 1 diabetes,” Kovatchev says. “Instead of a patient having to measure his or her blood sugar with a glucose meter several times a day and self-administer insulin injections, this system would continuously regulate the patient’s blood glucose, much like the way a non-diabetic’s pancreas functions.”
Complete results from the initial clinical trials at the UVA Health System, the University of Padova and the University of Montpellier, France are expected by the end of 2008.
Source-Newswise
SRM